Director, Rare Disease Health Economics and Outcomes Research

About the Department The Clinical, Medical and Regulatory (CMR) department at Novo Nordisk is one of the most diverse and collaborative groups within the organization. From healthcare provider interactions and developing and implementing regulatory strategies with the FDA to providing medical education and collecting data to support efficacy and new product development, CMR is involved. The one thing that keeps us all marching to the same beat is our patient centered focus. At Novo Nordisk, you will help patients around the world. As their needs evolve, so does our challenge to find better and more innovative ways to improve their quality of life. We’re changing lives for a living. Are you ready to make a difference? The Position The Rare Disease Health Economics and Outcomes Research Director, (HEOR), is responsible for assuring the development of best-in-class research strategies, policies, and plans that integrate health economics and outcomes research into clinical, medical and market access solutions to help build the economic and quality value proposition across all stages of the lifecycle for NN Rare Disease products in the U.S. Relationships This position reports directly to the Senior Director, Clinical Data Science & Evidence and has broad responsibility for managing multiple internal relationships within and across NNI and NN A/S. Internally, the incumbent works in close collaboration with leadership in Rare Disease and more broadly within CMR, Market Access and Public Affairs, Marketing, Legal as well as Global functions to deliver an integrated, long-term and impactful Evidence Generation Plans for all key products in the Rare Disease Therapeutic Area. Essential Functions The Director, is responsible for providing strategic vision, expertise, leadership, and direction to the TA HOER evidence generation team The Director guides the team responsible for developing the strategic, long-term and integrated Evidence Generation Plans (EGPs) for key products. The team ensures that the evidence is generated based on relevant research questions that are aligned with NNI business priorities. These plans are the drivers for all evidence generation activities across NNI The Director is responsible for engaging with the Field Medical Affairs and commercial field teams to ensure that EGPs outline evidence that is user friendly, relevant, high quality and communicated during customer conversations To support these activities, the incumbent is responsible for owning the evidence generation planning process, interfacing with key high-level leaders to drive the process, ensure alignment of commercial and medical to deliver an integrated and impactful evidence generation plan for all key products Assures that U.S. strategic insights and inputs are provided to shape Global project teams through the Integrated Evidence Planning (IEP) process Establishes, oversees implementation, and monitors adherence to administrative policies and procedures including those guiding evidence planning Responsible for evidence generation annual budget, assures evidence generation investments (research, tools, models, publications, field liaisons) are planned and mapped to driving attainment of goals and priorities Ensures commercial alignment of HEOR research and initiatives with brands, public affairs, market access and medical strategies. Ensures strategic alignment of health economics function with pricing, contracting and marketing to ensure that pricing decisions and brand strategies reflect a good understanding of the need to demonstrate value to customers Oversees health economics activities to the planning for analyses and cost models that demonstrate the cost-effectiveness and overall value of the brands, and overall product portfolio to specific accounts and customer channels. Helps to ensure health economics perspectives are incorporated in local and global clinical study designs, and in the company's health policy initiatives Physical Requirements 10-20% overnight travel required. Qualifications A PhD and/or master's degree in a quantitative health-related field (i.e. Health Economics, Pharmacoeconomics, Clinical Epidemiology or similar) 10+ years of experience in healthcare, payor, and/or pharmaceutical industry Strong interpersonal, collaborative, relationship building and communication skills Proven record of outstanding written and verbal communication and negotiation skills, with experience interacting with and presenting to key customers Demonstrated strategic thinking skills, strong business acumen, and excellent process and management skills Superior strategic/tactical planning experience within a pharmaceutical environment is required The incumbent must possess expertise, knowledge, experience and credibility to be viewed as an expert internally and externally, especially with key external groups such as large US payors, healthcare provider groups, key opinion leaders (KOLs), and industry and government expert groups In-depth knowledge of health care systems in the U.S., including managed care organizations, PBMs, health care delivery systems, Medicare, and Medicaid Record of peer-reviewed scientific publications, dossier development, and strategic, customer-focused HEOR tool development preferred Keen understanding of the drug development process Compensation & Benefits The base compensation range for this position is $250,000 to $320,000. Base compensation is determined based on a number of factors. This position is also eligible for a company bonus based on individual and company performance. Novo Nordisk offers long-term incentive compensation and or company vehicles depending on the position's level or other company factors. Employees are also eligible to participate in Company employee benefit programs including medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; employee assistance program; tuition reimbursement program; and voluntary benefits such as group legal, critical illness, identity theft protection, pet insurance and auto/home insurance. The Company also offers time off pursuant to its sick time policy, flex‑able vacation policy, and parental leave policy. Equal Opportunity Statement Novo Nordisk is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations. #J-18808-Ljbffr Merck & Co.